4.4 Review

Circular RNAs: Promising Molecular Biomarkers of Human Aging-Related Diseases via Functioning as an miRNA Sponge

期刊

出版社

CELL PRESS
DOI: 10.1016/j.omtm.2020.05.027

关键词

-

资金

  1. National Natural Science Foundation of China [81670456]
  2. Major Science and Technology Project for Significant New Drugs Creation [2018ZX09711001-003-011, 2018ZX09711001-012]
  3. Innovation Fund for Medical Sciences [2017-I2M-1-011]
  4. Beijing Municipal Natural Science Foundation [7162132]

向作者/读者索取更多资源

Circular RNAs (circRNAs) are a new class of noncoding single-stranded RNAs that differ from linear microRNAs (miRNAs), since they form covalently closed loop structures without free 30 poly(A) tails or 50 caps. circRNAs are the competitive endogenous RNAs (ceRNAs) by binding to miRNA through miRNA response elements (MREs) (i.e., miRNA sponge), thereby reducing the quantity of miRNA available to target mRNA, subsequently promoting mRNA stability or protein expression, which involves the initiation and progress of human diseases. Owing to these features of abundance, stability, conservative property, and tissue and stage specificity, widely distributing in the extracellular space and in various bodily fluids, circRNAs can be considered as potential biomarkers for various diseases. Here, we reviewed the promising circRNAs being disease biomarkers, focused on their regulatory function by acting as miRNA sponges, and described their roles in cancer, cardiovascular or neurodegenerative diseases, osteoarthritis, rheumatoid arthritis, diabetes, and other human aging-related diseases, which provide a new direction for pathogenesis, diagnosis, and treatment of human aging-related diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats

Shuyue Ren, Lingtai Jiao, Shiying Yang, Li Zhang, Junke Song, Haoying Yu, Jingrong Wang, Tingting Lv, Lan Sun, Yang Lu, Guanhua Du

PHARMACEUTICS (2020)

Letter Biochemistry & Molecular Biology

Bexarotene combined with lapatinib for the treatment of Cushing's disease: evidence based on drug repositioning and experimental confirmation

Haoying Yu, Shuyue Ren, Jingrong Wang, Tingting Lv, Lan Sun, Guanhua Du

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

暂无数据